ATOSSA THERAPEUTICS, INC. Additional Paid in Capital, Preferred Stock
ATOSSA THERAPEUTICS, INC. (ATOS) had Additional Paid in Capital, Preferred Stock of $626.00 thousand as of 2020-06-30, per its 10-Q filed 2020-08-13.
Discontinued › Balance Sheet › Equity, Attributable to Parent › Additional Paid in Capital
us-gaap:AdditionalPaidInCapitalPreferredStock · last filed 2020-08-13
- 2020-06-30: Additional Paid in Capital, Preferred Stock $626.00K.
- 2020-03-31: Additional Paid in Capital, Preferred Stock $671.00K.
- 2019-12-31: Additional Paid in Capital, Preferred Stock $671.00K.
- 2019-09-30: Additional Paid in Capital, Preferred Stock $671.00K.
| Period end | Additional Paid in Capital, Preferred Stock |
|---|---|
| 2020-06-30 | $626.00K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $671.00K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $671.00K 10-Q · filed 2020-08-13 |
| 2019-09-30 | $671.00K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $676.00K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $702.00K 10-Q · filed 2019-05-13 |
| 2018-12-31 | $2.38M 10-K · filed 2020-03-26 |
| 2018-09-30 | $3.52M 10-Q · filed 2018-11-14 |
| 2017-06-30 | $744.98K 10-Q · filed 2017-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |